Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Gastrointestinal Cancers

Keymed Biosciences New York China California

View original content:https://www.prnewswire.co.uk/news-releases/keymed-biosciences-announces-approval-of-ind-for-cm518d1-by-the-national-medical-products-administration-of-china-for-the-treatment-of-gastrointestinal-cancers-302438097.html